56 results
8-K
ONCSQ
ONCOSEC MEDICAL Inc
27 Dec 22
Departure of Directors or Certain Officers
5:00pm
, on December 26, 2022, the Board approved cash bonus retention awards for certain members of the Company’s leadership team, pursuant to which the Company … will provide a cash incentive designed to retain such employees (the “Retention Bonuses”).
Pursuant to the terms of the Retention Bonuses, eligible
8-K
EX-10.2
ONCSQ
ONCOSEC MEDICAL Inc
1 Dec 22
OncoSec Announces Pricing of $3.5 Million Public Offering
4:57pm
or the retention of the Placement Agent hereunder, all of which are hereby expressly waived.
SECTION 8. CLOSING. The obligations of the Placement Agent
424B3
ONCSQ
ONCOSEC MEDICAL Inc
1 Dec 22
Prospectus supplement
4:56pm
the collection, use, disclosure, retention, security and transfer of personal data, including the European Union General Data Privacy Regulation, which … expenditures for employee transition, notice period and severance payments, retention bonus payments, and related costs as well as non-cash expenses
8-K
c0ptpor7
4 Oct 22
OncoSec Announces Pipeline Prioritization and Workforce Reduction
5:28pm
8-K
EX-3.2
vezwbdsrzhjqalq
17 Dec 21
Departure of Directors or Certain Officers
9:27am
8-K
EX-10.1
yexrznluloeefk
16 Aug 21
Departure of Directors or Certain Officers
4:00pm
424B5
psb9vujxq da67n
21 Jan 21
Prospectus supplement for primary offering
5:11pm
424B5
jaaztuh
20 Jan 21
Prospectus supplement for primary offering
5:05pm
424B5
6e2gu 5u6doc80f
17 Aug 20
Prospectus supplement for primary offering
11:04am